Cardinal Health Secures $4B Revolving Credit — CAH

The $4.0 billion revolving credit facility gives Cardinal Health additional committed liquidity through 2031, providing medium-term flexibility for working capital, integration financing and opportunistic uses tied to management’s acquisitive strategy. Management has signaled an emphasis on building higher-margin services through acquisitions (MSOs, at-Home Solutions and related platforms), and the new facility sits alongside reported cash balances to increase optionality. Cardinal’s recent acquisition activity has been sizable and front-loaded: ION (Dec 2024, $1.1B), GIA (73% interest, Jan 2025, $2.8B cash consideration), ADS (Apr 2025, $1.1B), and Solaris Health (Nov 2025, $1.9B). Those transactions, and ongoing integration efforts into platforms such as Navista and Specialty Alliance, help explain the company’s need for committed liquidity beyond cash on hand. Investors should also weigh the financing cost implications. Acquisition-related financing drove higher net interest expense in early FY2026 (reported net interest of $80M in Q1 FY2026 versus $32M in the prior period). A revolving facility reduces reliance on short-term unsecured options but can affect leverage and interest expense depending on utilization and market rates. Finally, the facility reduces near-term liquidity risk but does not eliminate operational or legal exposures. Cardinal remains exposed to opioid litigation, reimbursement and tariff pressures, customer-concentration effects (for example, the impact of OptumRx contract dynamics), and integration execution risk across acquired MSOs and service platforms. The facility provides financial breathing room, but investors should monitor utilization, covenant terms, interest costs and the progress of integration and litigation outcomes.